Skip to content

CDR

Camber launches generic Opana

Camber launches generic Opana

PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of oxymorphone tablets to our growing portfolio of products. Oxymorphone tablets are the generic version of Opana from Endo Pharmaceuticals and is used to treat moderate to severe pain.

Fruth Pharmacy teams with LeSage Water

Fruth Pharmacy teams with LeSage Water

POINT PLEASANT, W. Va. –  “It’s about the mission,” began Matt Muller, sales and distribution manager for LeSage Natural Water, “LeSage Water is about creating job opportunities for disabled people. Our people love to come to work, they always arrive early, and they love what they do.

Gallo acquires Rancho Real Vineyard

Gallo acquires Rancho Real Vineyard

An affiliate of E. & J. Gallo Winery (Gallo) announced today it has purchased Rancho Real Vineyard in the Santa Maria Valley appellation of Santa Barbara County. Located along Highway 101, the 436-acre property sits 13 miles southeast of the town of Santa Maria.

Dr Pepper Snapple helping keep America beautiful

Dr Pepper Snapple helping keep America beautiful

Public space recycling efforts in dozens of communities across the U.S. will be getting a boost this spring thanks in part to a significant contribution by Dr Pepper Snapple Group in partnership with national nonprofit Keep America Beautiful.

Southern states top Walgreens Flu Index for 2017-2018

Southern states top Walgreens Flu Index for 2017-2018

Walgreens released its season-ending Flu Index, ranking the top states and markets (DMAs) for flu activity this season. The Index is based on methodology that includes Walgreens aggregate prescription data from September 2017 through March 2018.

Upsher-Smith releases Doxazosin tablets

Upsher-Smith releases Doxazosin tablets

Upsher-Smith Laboratories, LLC (Upsher-Smith) announced the launch of Doxazosin tablets, USP, 1 mg, 2 mg, 4 mg and 8 mg. The product was approved by the U.S. Food and Drug Administration (FDA) on April 17, 2018.

Bausch + Lomb ULTRA gets FDA approval for extended wear

Bausch + Lomb ULTRA gets FDA approval for extended wear

Bausch + Lomb announced that the U.S. Food and Drug Administration (FDA) has approved the Bausch + Lomb ULTRA family of contact lenses for extended wear of up to six nights and seven days of continuous wear. First introduced in the United States in 2014, Bausch + Lomb ULTRA is the only

Retail evolution bodes well for nonprescription meds

Retail evolution bodes well for nonprescription meds

Changes on the retail scene bode well for the consumer health care products market because they show that chains are trying to stay engaged with their customers, says Consumer Healthcare Products Association (CHPA) chairman and Clarion Brands chief executive officer Gary Downing.

Amneal launches generic for Sabril

Amneal launches generic for Sabril

Amneal Pharmaceuticals has launched vigabatrin for oral solution USP, a generic equivalent for Sabril. This is the second generic vigabatrin product currently on the market. Each carton contains fifty 500 mg packets. The finished dosage form is manufactured in the United States.